Contact

Scientific Advisory Board

Our Scientific Advisory Board brings together leading experts in infectious disease, antimicrobial research, clinical medicine, and pharmaceutical development to guide our innovation and ensure scientific rigor.

Scientific Advisory Board Members

Advisory Board-Wound Care & Limb Salvage Team

David Allie

, M.D. BOD-Louisiana Board Certified in Cardiothoracic and Vascular surgery and General Surgery

Mark Granick, M.D. -New Jersey

Wound Care and Plastic Surgery Medical Advisor

Lawrence Harkless, DPM -Texas

Wound Care Medical Advisor

openart-image_6gB28L6I_1770324281257_raw

Michael Torsiello, MD -New Jersey

Wound Care and Limb Salvage - Plastic Surgeon

Advisory Board -Infections Disease Team

Edward J. Septimus, M.D.

Infectious Disease Medical Advisor

Paul Auwaerter, MD

Infections Disease Medical Advisor

Respiratory Team

Howard Levine, M.D.

ENT and Sleep Medical Advisor

Carlos Baleeiro, M.D.

Pulmonology and Respiratory Advisor

Thomas O’Donnell, M.D

openart-image_E0T7wx-P_1770324359786_raw

Ron Iannacone, DO, FAOCO

Advisory Board –OBGYN -Urology Team

Monty Heinen, MD. OBGYN

Damian Badeaux MD. OBGYN –LA

Thomas R. Jarnagin, MD OBGYN

openart-image_tN8X5eb5_1770324453250_raw

Samantha Vidrine, MD OBGYN

Medical Advisory Board

Russ Granich, MD

Hospice and Nursing Home Care Medical Advisor, Connecticut

Karim Paracha, M.D.

Wound Care and Limb Salvage -New York

Matthew Abraham, MD

Emergency Critical Care Subspecialty of Sleep Medicine Lafayette, LA

openart-image_yyEfeJt9_1770324478834_raw

Albert Gros,MD

Pain ManagementMedicalAdvisor –Lafayette, Louisiana

Raymond Lee Chilton, MD

Emergency Critical Care Austin, Texas

Brad Boudreaux, MD

Emergency Room/Critical Care Lafayette, LA

Disclosure

DISCLOSURE for R&D Products
Research and pipeline products are currently in the early stages of development and have not been cleared or approved by the U.S. Food and Drug Administration (FDA). These products are not in clinical trials and are not available for sale or commercial distribution in the United States. The safety and effectiveness have not yet been established. Statements regarding its potential use are based on in vitro or preclinical data and are for informational purposes only. 

This page provides scientific and clinical information related to the development of innovative chemistries and proteomic approaches designed by Spectrum Antimicrobials team to advance new medical product and drugs for better control, prevention, and treatment of infection. Our scientific mission is to reduce reliance on ineffective or overused antibiotics and antimicrobials through evidence-based innovation.

Information presented on this site is solely provided for informational purposes and cannot be used to support any commercial use of our products in any parts pf the word. All products are cleared and/or approved on a country-by-country basis in accordance with applicable local regulatory requirements. Any use outside of approved indications or labeling is strictly prohibited.

No commercial products may be ordered, and no promotional materials for any commercial product are offered through this website worldwide. For product inquiries or purchasing information, please contact sales@spectrumantimicrobials.com or visit our designated e-commerce website (xx@.com).

I CONSENT